Volpi Group Video
See how Volpi can help you to reduce complexity for design, development, and manufacturing of smart optical module solutions for in vitro diagnostics (IVD) and life sciences instruments.
Read More
White paper: Point of Care Testing
Simplifying market access for Point of Care solution providers Given increased interest in areas such as antimicrobial resistance (AMR) and viral/bacterial patient stratification, Point of Care Testing (POCT) has recently attracted a lot of attention. With the entry of large diagnostic solution providers in the POCT market, a strong competition on market shares can be
Read MoreVolpi’s Offering in the Field of OEM qPCR-Measurement Systems
The challenges Quantitative polymerase chain reaction or qPCR, sometimes called real-time PCR, simultaneously detects and measures the amount of a specific DNA target in a sample by amplifying that target during cycles of heating and cooling the sample. Since its development in the early 1990s, qPCR has become an essential part of many molecular diagnostic
Read MoreFluorescence Calibration Tools
The challenge Many IVD assays and devices rely on fluorescence emission and detection. This is particularly true in the field of molecular diagnostics, where real-time PCR and other instruments that detect and process fluorescent dye signals are used every day in both research and clinical laboratories. Calibration of fluorimeters in in vitro diagnostic (IVD) devices
Read MoreLED Light Engines as Substitutes for Halogen-Based Illumination in IVD
The challenge Many clinical chemistry and immunology readers on the market today for diagnostic testing still use halogen-bulb-based illumination modules with excitation filters to help obtain the photometric sample readout. Some of the analyzed signals used in these readouts have wavelengths of between 340 and 380 nanometers (nm). Because halogen bulbs emit light based on
Read MoreVolpi USA ISO 13485 Certification Announcement
AUBURN, USA, Oct. 28, 2016 The Volpi Group today announced that its U.S. branch has earned ISO 13485 certification. The certification demonstrates that Volpi USA has met the highest international standard for quality management systems used in the design and manufacture of medical devices. Volpi USA’s ISO 13485 certification complements the same accreditation achieved by its Swiss
Read MoreVolpi Group partners with QIAGEN to manufacture the imaging module for the GeneReader NGS platform
SCHLIEREN, Switzerland, Feb. 8, 2016 The Volpi Group, a 60-year-old optical electronics firm based in Schlieren, Switzerland, today announced that it is collaborating with QIAGEN Instruments AG on the manufacture of the automated fluorescence imaging module used in QIAGEN’s GeneReaderTM next-generation sequencing (NGS) instrument. The benchtop GeneReader combines with other QIAGEN NGS products to provide
Read More2015 International Year of Light and Light-Based Technologies
The UN General Assembly proclaimed 2015 as the International Year of Light and Light-based Technologies (IYL 2015). The International Year of Light is a global initiative which will highlight to the citizens of the world the importance of light and optical technologies in their lives, for their futures, and for the development of society. It
Read MoreSeahorse Bioscience liaises with Volpi for XFe Extracellular Flux Analyzer
Billerica, Massachusetts and Auburn, New York, USA – November 3rd, 2014 Seahorse Bioscience Inc. and Volpi USA Inc., a subsidiary of the Swiss headquartered Volpi Group liaises for the development and manufacturing of optical modules for the Seahorse XFe Extracellular Flux Analyzer. The XF instruments analyze mitochondrial respiration and glycolysis in live cells, generating data
Read MoreUS Representative Dan Maffei, Bio/Med leaders discuss ways to address job creation, manufacturing/R&D leadership
U.S. Representative Dan Maffei, Bio/Med Leaders discuss ways to address job creation, manufacturing/R&D leadership at the Auburn manufacturing facility of New York-based Volpi. > For full Report see Newsroom of the MedTech Association Press contact:Thomas TrachslerDirector Program Management+41 44 732 43 43trachsler@volpi.ch
Read More